LGND Year to date has changed +10.19% percent. +29.43% in

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
LGND Year to date has changed +10.19% percent. +29.43% in the last 30 days. $LGND

Ligand Pharmaceuticals Inc Full breakdown
Last price 57.96
Weighted Alpha +1.22
YTD Percent +10.19%
1-Month Percent +29.43%
3-Month Percent +5.59%
1-Year Percent +18.12%

More about Ligand Pharmaceuticals Inc
http://investorshangout.com/Ligand-Pharmaceut...GND-54621/

Ligand Pharmaceuticals Inc. (LGND) Stock Research Links

LGND Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mastering Power Efficiency with Phase Converters

Updated Category News Views 9

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Better Home & Finance Faces Class Action Lawsuit

Updated Category News Views 0

Securities Lawsuit Looms Over Better Home & Finance Another day, another company caught in the crosshairs of the law. This time, it’s Better Home & Finance Holding Company (NASDAQ: BETR) getting a dressing down for allegedly breaching securities laws. With lawsuits flying around like confetti, the seasoned traders among us can't help but grit our teeth and take notice....

Continue Reading
Goodyear Preps for Q3 2026 Earnings Report, Call

Updated Category News Views 2

Gearing Up for Goodyear's Latest Financials Here we go, folks—Goodyear Tire & Rubber Company is ready to roll out their third quarter's financial results for 2026. Come November 4, after the market goes to sleep, the big wigs at Goodyear will toss out the numbers. We’ll all get the chance to dig into the figures that they’ll slap on their investor website. Then,...

Continue Reading
AppLovin Faces Lawsuit Over AI Claims: Investor Alert

Updated Category News Views 4

AI Promises or Pipedreams? AppLovin Corporation finds itself in a bit of hot water, and if you've got skin in this game, you've probably felt the heat. So, what's stirring the pot? A class action lawsuit against AppLovin (NASDAQ: APP) for allegedly pulling the wool over investors' eyes with overstated claims about their generative AI tool. Class Action: Weighing the...

Continue Reading
Burger King Unveils Hello Kitty® Partnership Frenzy

Updated Category News Views 5

Burger King's Hello Kitty® Move: Fad or Brilliant? Few things scream nostalgia like Hello Kitty® and a Burger King kids' meal. It's the kind of combo that makes you wonder if we're simply riding a wave of kawaii nostalgia or if this is a masterstroke tapping into a multi-generational goldmine. What's in the Box? Burger King isn't playing around. Starting October 20,...

Continue Reading
Ardelyx Investors Face Lawsuit Over Misleading Claims

Updated Category News Views 2

Investors Land in Hot Water with Ardelyx Alright, folks, here we go again. New York's courtroom dramas are in full swing with Ardelyx, Inc. at center stage, and not in a good way. The DJS Law Group has rallied the troops, reminding investors caught in the storm of a class action lawsuit. Specifically, it's all about alleged violations of the Securities Exchange Act of...

Continue Reading
Endava's Stock Tumble Sparks Investor Class Action

Updated Category News Views 6

A Rocky Day for Endava Investors Here's the thing, on September 21, 2026, Endava plc hit a rough patch that left a mark. After the market closed, the company announced that it had put its Chief Financial Officer, Mark Thurston, on administrative leave. This wasn't just a routine shuffle; it came on the heels of the Board's Audit Committee finding reason to probe into...

Continue Reading
Alaska Air Group's Q3: Facing Headwinds and Strategies

Updated Category News Views 4

Weathering the Q3 Storm Alaska Air Group's third quarter results are in the bag, and let me tell ya, it's a mixed bag of sour lemons and hopeful limes. Reporting a net loss of $147 million or ($1.32) per share ain't the kind of results that plaster smiles on investors' faces. But hey, it's a volatile sector if there ever was one, especially with fuel costs ballooning to a...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 4

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
Dairy Blends Market Eyes USD 15.38B by 2035 Growth

Updated Category News Views 3

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

Continue Reading

Top 5 Most Recently Viewed Articles

Editas Medicine Set to Present at the ESGCT Annual Congress

Updated Category News Views 182

Editas Medicine's Upcoming Presentation Highlights Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene...

Continue Reading
Innovative Solutions for Medical Devices: ICP DAS-BMP at COMPAMED

Updated Category News Views 193

ICP DAS-BMP Showcases Medical Innovations at COMPAMED ICP DAS-BMP, a prominent manufacturer from Taiwan, is gearing up for the prestigious COMPAMED event taking place in Germany. This event, which draws significant attention from the medical device industry, showcases advancements in medical-grade thermoplastic polyurethane (TPU) materials. Focus on Low-Migration and...

Continue Reading
Broadcom's Performance and ETF Options for Investors

Updated Category News Views 217

Broadcom's Recent Performance and Growth Potential Broadcom Inc. has made headlines recently with its remarkable performance in the tech sector. Following a solid earnings report for the second quarter, this semiconductor leader has seen its stock, designated as AVGO, score a notable jump of nearly 19% year-to-date. This surge has been particularly impressive, as the...

Continue Reading
InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO

Updated Category News Views 236

InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO InCarda Therapeutics, a clinical-stage biopharmaceutical firm dedicated to developing cutting-edge treatments for cardiac arrhythmias, has appointed Dr. Myles Greenberg, MD, MBA, as its new Chief Executive Officer. Dr. Greenberg is set to lead the company as they work on their flagship product, an orally inhaled...

Continue Reading
Jim Cramer's Insight: A Tipping Point for Nvidia's Stock

Updated Category News Views 148

Understanding Jim Cramer's Perspective on Nvidia CNBC’s Jim Cramer hinted at a potential turning point for NVIDIA Corp. (NASDAQ: NVDA) after the stock reached $127. This could signal a bottom for the semiconductor giant after its recent setbacks. Market Dynamics: What Cramer Noted Cramer’s Observations According to Cramer, the $127 mark could indicate a pivotal moment...

Continue Reading